Aims Catheter ablation (CA) of ventricular tachycardia (VT) has become an important tool to
improve clinical outcomes in patients with appropriate transvenous implantable cardioverter …

Background: Despite the benefits of implantable cardioverter-defibrillator (ICD) therapy,
inappropriate shocks can lead to multiple adverse effects. The aim of this study was to clarify …

A noninvasive, effective approach for immediate and painless heart pacing would have
invaluable implications in several clinical scenarios. Here we present a novel strategy that …

Background The aim of this study was to determine overall and aetiology-related incidence
of secondary prevention ICD implantation over the last 15 years in Canton Ticino and to …

Background Anti-tachycardia pacing therapy (ATP) has shown comparable efficacy to shock
therapy in ventricular tachycardia (VT) termination with better quality of life. However, some …

Background Anti‐tachycardia pacing (ATP) delivered from an implantable device is a useful
tool to terminate ventricular tachycardia (VT). But its real‐world efficacy for those patients …

Introduction Although antitachycardia pacing (ATP) is effective in terminating ventricular
tachyarrhythmias in patients with implantable cardioverter defibrillators (ICDs), the efficacy of …

Background Anti‐tachycardia pacing (ATP) delivered from an implantable device is an
important tool to terminate ventricular tachycardia (VT). But its real‐world efficacy for fast VT …

Background Atrial fibrillation (AF) and ventricular arrhythmias (VAs) are associated with
increased morbidity and mortality. However, data are lacking concerning the association of …

Abstract Background The PainFree Smart Shock Technology (SST) study showed a low
implantable cardioverter‐defibrillator (ICD) inappropriate shock rate. However, the majority …